Literature DB >> 6543709

Multiple phenotypic divergence of mammary adenocarcinoma cell clones. I. In vitro and in vivo properties.

D R Welch, D B Krizman, G L Nicolson.   

Abstract

The properties of cell clones derived from locally growing and spontaneous metastases of 13762NF mammary adenocarcinoma change during in vitro growth. This has been termed phenotypic drift and is reproducible in independent experiments using different cryoprotected cell stocks. To determine whether phenotypic drift in 13762NF cell clones is the result of an en bloc shift in the properties of all tumor cells, or independent phenotypic divergence of tumor cells to produce a mixed cell population, local tumor-derived clone MTF7 was subcloned at low and high culture passage numbers in vitro. Each subclone was analyzed in vitro for cell morphology, growth rate, saturation density, karyotype and ploidy, and in vivo for experimental metastatic behavior. Subclones derived from low passage clone MTF7 (T11; tissue culture passage number 11) were relatively homogeneous in their growth rates (doubling times of 16.8-17.4 h) and saturation densities (approximately 2 X 10(5) cells/cm2); yet, these same subclones were heterogeneous in their in vitro cell morphologies, experimental metastatic potentials (means range from 0 to greater than 100 tumor nodules per lung), size distributions of lung tumor nodules, marker chromosomes and modal chromosome numbers. High passage MTF7 (T35; tissue culture passage number 35) subclones had similar growth rates and saturation densities, except for subclone 2, which had a doubling time of approximately 26 h. Cell morphologies, experimental metastatic potentials (means range from 3 to greater than 600 tumor nodules per lung), size distribution of lung tumor nodules, marker chromosomes and modal chromosome numbers varied between MTF7 (T35) subclones. The results suggest that simultaneous, independent divergence of several phenotypes from a single cloned cell occurred to form a mixed cell population containing cells with independently segregated, unrelated phenotypes. Thus, the reproducibility of phenotypic drift in clonal cell populations was probably the result of tumor cell divergence and was not an en bloc shift in phenotypic properties of all cells.

Entities:  

Mesh:

Year:  1984        PMID: 6543709     DOI: 10.1007/bf00135172

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  42 in total

Review 1.  Tumor heterogeneity.

Authors:  G H Heppner
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

2.  Shifts in tumor cell phenotypes induced by signals from the microenvironment. Relevance for the immunobiology of cancer metastasis.

Authors:  V Schirrmacher
Journal:  Immunobiology       Date:  1980-07       Impact factor: 3.144

Review 3.  Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells.

Authors:  G L Nicolson
Journal:  Biochim Biophys Acta       Date:  1982-12-21

4.  Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to adriamycin, 5-fluoro-2'-deoxyuridine and methotrexate treatment in vitro.

Authors:  D R Welch; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1983 Oct-Dec       Impact factor: 5.150

5.  Multiple phenotypic divergence of mammary adenocarcinoma cell clones. II. Sensitivity to radiation, hyperthermia and FUdR.

Authors:  D R Welch; D P Evans; S P Tomasovic; L Milas; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1984 Oct-Dec       Impact factor: 5.150

Review 6.  The implications of tumor heterogeneity for studies on the biology of cancer metastasis.

Authors:  I R Hart; I J Fidler
Journal:  Biochim Biophys Acta       Date:  1981-08-31

Review 7.  Generation of phenotypic diversity and progression in metastatic tumor cells.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

8.  Brain meninges tumor formation by in vivo-selected metastatic B16 melanoma variants in mice.

Authors:  T Kawaguchi; M Kawaguchi; K M Miner; T M Lembo; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1983 Jul-Sep       Impact factor: 5.150

9.  Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.

Authors:  K M Miner; J Klostergaard; G A Granger; G L Nicolson
Journal:  J Natl Cancer Inst       Date:  1983-04       Impact factor: 13.506

10.  Phenotypic drift of metastatic and cell-surface properties of mammary adenocarcinoma cell clones during growth in vitro.

Authors:  A Neri; G L Nicolson
Journal:  Int J Cancer       Date:  1981-12       Impact factor: 7.396

View more
  19 in total

Review 1.  The significance of biological heterogeneity.

Authors:  H Rubin
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

2.  Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties.

Authors:  James M Rae; Susan J Ramus; Mark Waltham; Jane E Armes; Ian G Campbell; Robert Clarke; Robert J Barndt; Michael D Johnson; Erik W Thompson
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

Review 3.  Implications of tumor progression on clinical oncology.

Authors:  D R Welch; S P Tomasovic
Journal:  Clin Exp Metastasis       Date:  1985 Jul-Sep       Impact factor: 5.150

4.  EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism.

Authors:  J E Segall; S Tyerech; L Boselli; S Masseling; J Helft; A Chan; J Jones; J Condeelis
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

5.  Chromosome and DNA analyses of rat 13762NF mammary adenocarcinoma cell lines and clones of different metastatic potentials.

Authors:  V Pearce; S Pathak; D Mellard; D R Welch; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1984 Oct-Dec       Impact factor: 5.150

6.  Multiple phenotypic divergence of mammary adenocarcinoma cell clones. II. Sensitivity to radiation, hyperthermia and FUdR.

Authors:  D R Welch; D P Evans; S P Tomasovic; L Milas; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1984 Oct-Dec       Impact factor: 5.150

7.  Metastatic instability of murine tumor metastases: dependence on tumor type.

Authors:  J P Volpe; L Milas
Journal:  Clin Exp Metastasis       Date:  1988 Jul-Aug       Impact factor: 5.150

8.  Use of NeoR B16F1 murine melanoma cells to assess clonality of experimental metastases in the immune-deficient chick embryo.

Authors:  A F Chambers; S Wilson
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

9.  Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma.

Authors:  S D Pencil; Y Toh; G L Nicolson
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Isolation and characterization of low- and high-metastatic clones from murine RCT (Radiological, Chiba, and Toyama) sarcoma.

Authors:  H Matsui; S Tatezaki; H Tsuji; H Ochiai
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.